These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8709265)

  • 1. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues.
    Yang Y; Su Q; Grewal IS; Schilz R; Flavell RA; Wilson JM
    J Virol; 1996 Sep; 70(9):6370-7. PubMed ID: 8709265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions.
    Chirmule N; Tazelaar J; Wilson JM
    J Immunol; 2000 Jan; 164(1):248-55. PubMed ID: 10605018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
    Jooss K; Turka LA; Wilson JM
    Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
    Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
    Yang Y; Wilson JM
    Science; 1996 Sep; 273(5283):1862-4. PubMed ID: 8791591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
    Andreasen SO; Christensen JE; Marker O; Thomsen AR
    J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the immune response after local delivery of recombinant adenovirus in murine pancreas and successful strategies for readministration.
    McClane SJ; Chirmule N; Burke CV; Raper SE
    Hum Gene Ther; 1997 Dec; 8(18):2207-16. PubMed ID: 9449374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.
    Jooss K; Yang Y; Wilson JM
    Hum Gene Ther; 1996 Aug; 7(13):1555-66. PubMed ID: 8864756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions.
    Chirmule N; Raper SE; Burkly L; Thomas D; Tazelaar J; Hughes JV; Wilson JM
    J Virol; 2000 Apr; 74(7):3345-52. PubMed ID: 10708452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs.
    Chirmule N; Hughes JV; Gao GP; Raper SE; Wilson JM
    J Virol; 1998 Jul; 72(7):6138-45. PubMed ID: 9621078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
    Yang Y; Haecker SE; Su Q; Wilson JM
    Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer.
    Merritt RE; Mahtabifard A; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1609-17. PubMed ID: 14666041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic barriers to hepatic adenoviral gene therapy for transplantation.
    DeMatteo RP; Chu G; Ahn M; Chang E; Burke C; Raper SE; Barker CF; Markmann JF
    Transplantation; 1997 Jan; 63(2):315-9. PubMed ID: 9020337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse.
    Tripp RA; Jones L; Anderson LJ; Brown MP
    J Immunol; 2000 Jun; 164(11):5913-21. PubMed ID: 10820273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
    Croyle MA; Chirmule N; Zhang Y; Wilson JM
    J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
    Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
    Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.